EO-14367
Designating Fentanyl as a Weapon of Mass Destruction
- Signed
- Dec 15, 2025
- Published
- Dec 18, 2025
Federal Register: 2025-23417
Source: Federal Register.
Designates Illicit Fentanyl as a Weapon of Mass Destruction
What it does
This order formally designates illicit fentanyl and its core precursor chemicals as Weapons of Mass Destruction (WMD). It directs the Attorney General to pursue fentanyl trafficking prosecutions with enhanced sentencing, the Secretaries of State and Treasury to pursue sanctions against involved assets and financial institutions, and the Department of Defense to assess whether military resources should support law enforcement under 10 U.S.C. §282. It also directs the Department of Homeland Security to apply WMD and nonproliferation intelligence tools to counter-fentanyl operations.
Who benefits
Communities with high rates of fentanyl overdose deaths, particularly rural and lower-income urban areas. Family members of overdose victims. Law enforcement agencies that would receive expanded tools and potential military support. Federal prosecutors seeking stronger sentencing leverage. Border security personnel. Communities in Mexico and Central America affected by cartel violence funded by drug trafficking.
Who is affected
Individuals charged with fentanyl-related offenses who could face steeper sentences under enhanced sentencing provisions. Defense attorneys and civil liberties advocates concerned about expanded prosecutorial power. Legitimate pharmaceutical manufacturers and distributors of fentanyl-based medications who may face increased regulatory scrutiny. Chemical companies that produce precursor chemicals for lawful purposes. Foreign nationals and financial institutions subject to new Treasury sanctions. Harm reduction organizations whose clients may face harsher criminal consequences.
Supporters argue
Supporters argue that fentanyl's extreme lethality — with a lethal dose as small as two milligrams — and its use by organized criminal networks to fund terrorism and destabilize governments makes a WMD designation legally and strategically appropriate. They contend the designation unlocks a broader set of national security tools, including intelligence resources and potential military support, that are better suited to dismantling transnational trafficking networks than traditional drug enforcement alone, and that the president's Commander-in-Chief and Take Care Clause authority fully supports directing agencies to treat the fentanyl threat at this level.
Opponents argue
Opponents argue that applying the WMD label — a term defined in federal statute (18 U.S.C. §2332a) in the context of terrorism — to a controlled substance stretches the legal definition beyond its intended scope and could create confusion in prosecutions and intelligence operations. They contend that involving military resources in domestic drug enforcement raises serious Posse Comitatus Act concerns, and that enhanced sentencing without new legislation may conflict with existing Controlled Substances Act sentencing frameworks established by Congress, raising separation-of-powers questions about whether an executive order can effectively modify statutory sentencing structures.
Constitutional basis
Executive orders rest on constitutional authority or statutory delegation. This summary describes the legal grounding cited or implied by the order.
The order cites the president's general constitutional authority under Article II. Specific relevant authorities include the Take Care Clause (Art. II, §3), which empowers the president to direct executive agencies in enforcing existing law; the Commander-in-Chief Clause (Art. II, §2, cl. 1), which supports directing the Department of Defense to assess resource deployment; and statutory authority under the Controlled Substances Act (21 U.S.C. §§841, 846) and 10 U.S.C. §282, which governs military assistance to civilian law enforcement for drug interdiction. The order does not invoke a formal national emergency statute such as IEEPA or the National Emergencies Act.